RA Capital Discloses New Passive Stake in Repros Therapeutics Inc (RPRX)

RA Capital Management, managed by Peter Kolchinsky, has revealed a new position in Repros Therapeutics Inc (NASDAQ:RPRX). RA Capital has disclosed a passive stake in the company, which amasses 6.2% of common stock, showed a new filing with the Securities and Exchange Commission. The position contains 1.44 million shares.

Peter Kolchinsky

Repros Therapeutics Inc (NASDAQ:RPRX) is engaged in the development of small molecule drugs for major unmet medical needs that treat male and female reproductive disorders.

For the three month period ended December 31, 2013, the company reported a net loss of $7.1 million, or $0.31 per share, compared to a net loss of $8.0 million, or $0.47 per share, for the same period in 2012. The decrease in net loss was primarily due to reduced clinical development expenses related to Androxal, partially offset by an increase in payroll and benefits expenses. For the 12-month period ended December 31, 2013, the company reported a net loss of $27.7 million, or $1.33 per share, compared to a net loss of $18.2 million, or $1.18 per share, for 2012.

Baker Bros. Advisors, managed by Julian Baker and Felix Baker, owns 2.78 million shares of Repros Therapeutics Inc (NASDAQ:RPRX). Another investor Jacob Gottlieb’s Visium Asset Management disclosed holding 1.84 million shares of the company at the end of the fourth quarter of 2013.

Boston-based RA Capital invests in companies with promising drugs and technologies. Last month, Ra Capital disclosed owning 2.43 million shares of Dicerna Pharmaceuticals Inc (NASDAQ:DRNA), equivalent to 14.6% of the common stock. In addition, the fund initiated a 7.2% passive stake in Furiex Pharmaceuticals Inc (NASDAQ:FURX), the position amassing 750,000 shares. In January, Ra Capital reported selling a total of 300,000 shares of Derma Sciences Inc (NASDAQ:DSCI).

RA Capital is also a fan of Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) and Sangamo Biosciences Inc. (NASDAQ:SGMO), owning 23.37 million shares and 5.23 million shares, respectively.

Disclosure: none

Recommended Reading:

Steven Cohen Ups His Bets on NQ Mobile Inc (ADR) (NQ)

Hedge Fund News: Thomas Steyer, Bill Ackman & Eric Mindich

Wexford Capital Decreases Exposure to Diamondback Energy Inc (FANG)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!